Serum insulin and growth hormone responses to arginine infusion before and during treatment with contraceptive steroids.
D001695:Biology; D002241:Carbohydrates; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004703:Endocrine System; D005040:Ethynodiol Diacetate; D005193:Family Planning Services; D005947:Glucose; D006728:Hormones; D006805:Human Experimentation; D008656:Mestranol; D008660:Metabolism; D010827:Physiology; D010907:Pituitary Hormones; D011446:Prospective Studies; D012106:Research
D002241:Carbohydrates; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D006728:Hormones; D010907:Pituitary Hormones; D005040:Ethynodiol Diacetate; D008656:Mestranol; D005947:Glucose
Biology; Carbohydrate Metabolic Effects; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Endocrine System; Ethynodiol Diacetate; Family Planning; Glucose Metabolism Effects; Hormones; Human Volunteers; Mestranol; Metabolic Effects; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Pituitary Hormones; Prospective Studies; Research Methodology; Studies